1887

Abstract

is a fastidious organism of the class the smallest prokaryote capable of independent replication. First isolated in 1981, much is still unknown regarding its natural history in untreated infection. It is recognized as a sexually transmitted pathogen causing acute and chronic non-gonococcal urethritis (NGU) in men, with a growing body of evidence to suggest it also causes cervicitis and pelvic inflammatory disease in women. Its role in several other clinical syndromes is uncertain. The majority of people infected remain asymptomatic and clear infection without developing disease; asymptomatic screening is therefore not recommended. Prevalence rates are higher in patients attending sexual health clinics and in men with NGU. Limited availability of diagnostics has encouraged syndromic management, resulting in widespread antimicrobial resistance and given that few antimicrobial classes have activity against , there is significant concern regarding the emergence of untreatable strains. There is a need for wider availability of testing, which should include detection of macrolide resistance mediating mutations. Expertise in interpretation of microbiological results with clinical correlation ensures targeted treatment avoiding unnecessary antibiotic exposure. Public health surveillance nationally and internationally is vital in monitoring and responding to changing epidemiology trends. In this review, we summarize current knowledge of , including epidemiology, clinical and microbiological data, and discuss treatment challenges in the era of rising multidrug resistance.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000830
2019-07-22
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/micro/10.1099/mic.0.000830/mic000830.html?itemId=/content/journal/micro/10.1099/mic.0.000830&mimeType=html&fmt=ahah

References

  1. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin Microbiol Rev 2011;24:498–514 [CrossRef]
    [Google Scholar]
  2. Le Roux MC. Mycoplasma genitalium: a brief review MC Le Roux, AA Hoosen. South Afr J Epidemiol Infect Peer Rev SAJEI South Afr J Epidemiol Infect. 2010;2525:2010–6
    [Google Scholar]
  3. Tully J, Cole R, Taylor-Robinson D, Rose D. A newly discovered mycoplasma in the human urogenital tract. The Lancet 1981;317:1288–1291 [CrossRef]
    [Google Scholar]
  4. Hyman HC, Yogev D, Razin S. Dna probes for detection and identification of Mycoplasma pneumoniae and Mycoplasma genitalium. J Clin Microbiol 1987;25:726-8
    [Google Scholar]
  5. Roberts MC, Hooton M, Stamm W, Holmes KK, Kenny GE. Dna probes for the detection of mycoplasmas in genital specimens. Isr J Med Sci 1987;23:618–620
    [Google Scholar]
  6. Hooton TM, Roberts MC, Roberts PL, Holmes KK, Stamm WE et al. Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis. Lancet 1988;1:266–268 [CrossRef]
    [Google Scholar]
  7. Palmer HM, Gilroy CB, Furr PM, Taylor-Robinson D. Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium. FEMS Microbiol Lett 1991;61:199–203 [CrossRef]
    [Google Scholar]
  8. Jensen JS, Uldum SA, Søndergård-Andersen J, Vuust J, Lind K. Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. J Clin Microbiol 1991;29:46–50
    [Google Scholar]
  9. McGowin CL, Totten PA. The unique microbiology and molecular pathogenesis of Mycoplasma genitalium. J Infect Dis 2017;216:S382–S388 [CrossRef]
    [Google Scholar]
  10. Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 2016;30:1650–1656 [CrossRef]
    [Google Scholar]
  11. Sonnenberg P, Ison CA, Clifton S, Field N, Tanton C et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third national survey of sexual attitudes and lifestyles (Natsal-3). Int J Epidemiol 2015;44:1982–1994 [CrossRef]
    [Google Scholar]
  12. McGowin CL, Anderson-Smits C. Mycoplasma genitalium: An emerging cause of sexually transmitted disease in women In Manchester M. editor PLoS Pathog7 2011; pe1001324 [CrossRef]
    [Google Scholar]
  13. Baumann L, Cina M, Egli-Gany D, Goutaki M, Halbeisen FS et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis. Sex Transm Infect 2018;94:255–262 [CrossRef]
    [Google Scholar]
  14. Cohen CR, Nosek M, Meier A, Astete SG, Iverson-Cabral S et al. Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis 2007;34:274–279 [CrossRef]
    [Google Scholar]
  15. Oakeshott P, Aghaizu A, Hay P, Reid F, Kerry S et al. Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. Clin Infect Dis 2010;51:1160–1166 [CrossRef]
    [Google Scholar]
  16. Lillis RA, Martin DH, Nsuami MJ. Mycoplasma genitalium infections in women attending a sexually transmitted disease clinic in new orleans. Clin Infect Dis 2018;18: [CrossRef]
    [Google Scholar]
  17. Trent M, Coleman JS, Hardick J, Perin J, Tabacco L et al. Clinical and sexual risk correlates of Mycoplasma genitalium in urban pregnant and non-pregnant young women: cross-sectional outcomes using the baseline data from the Women's BioHealth Study. Sex Transm Infect 2018;94:411–413 [CrossRef]
    [Google Scholar]
  18. Ma L, Taylor S, Jensen JS, Myers L, Lillis R et al. Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol 2008;8:130 [CrossRef]
    [Google Scholar]
  19. Hjorth SV, Björnelius E, Lidbrink P, Falk L, Dohn B et al. Sequence-Based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol 2006;44:2078–2083 [CrossRef]
    [Google Scholar]
  20. Dionne-Odom J, Geisler WM, Aaron KJ, Waites KB, Westfall AO et al. High prevalence of multidrug-resistant Mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in Alabama. Clin Infect Dis 2018;66:796–798 [CrossRef]
    [Google Scholar]
  21. Soni S, Alexander S, Verlander N, Saunders P, Richardson D et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect 2010;86:21–24 [CrossRef]
    [Google Scholar]
  22. Kapiga SH, Sam NE, Mlay J, Aboud S, Ballard RC et al. The epidemiology of HIV-1 infection in northern Tanzania: results from a community-based study. AIDS Care 2006;18:379–387 [CrossRef]
    [Google Scholar]
  23. Mavedzenge SN, Van Der Pol B, Weiss HA, Kwok C, Mambo F et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS 2012;26:617–624 [CrossRef]
    [Google Scholar]
  24. Perez G, Skurnick JH, Denny TN, Stephens R, Kennedy CA et al. Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. Int J Infect Dis 1998;3:5–11 [CrossRef]
    [Google Scholar]
  25. Sethi S, Zaman K, Jain N. Mycoplasma genitalium infections: current treatment options and resistance issues. Infect Drug Resist 2017;10:283–292 [CrossRef]
    [Google Scholar]
  26. Seña AC, Lee JY, Schwebke J, Philip SS, Wiesenfeld HC et al. A silent epidemic: the prevalence, incidence and persistence of Mycoplasma genitalium among young, asymptomatic high-risk women in the United States. Clin Infect Dis 2018;67:73–79 [CrossRef]
    [Google Scholar]
  27. Taylor-Robinson D, Gilroy CB, Thomas BJ, Hay PE. Mycoplasma genitalium in chronic non-gonococcal urethritis. Int J STD AIDS 2004;15:21–25 [CrossRef]
    [Google Scholar]
  28. Wikström A, Jensen JS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 2006;82:276–279 [CrossRef]
    [Google Scholar]
  29. Read TRH, Jensen JS, Fairley CK, Grant M, Danielewski JA et al. Use of pristinamycin for macrolide-resistant Mycoplasma genitalium Infection. Emerg Infect Dis 2018;24:328–335 [CrossRef]
    [Google Scholar]
  30. Falk L, Fredlund H, Jensen JS. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Infect 2003;79:318–319 [CrossRef]
    [Google Scholar]
  31. Ma L, Mancuso M, Williams JA, Van Der Pol B, Fortenberry JD et al. Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection. Infect Immun 2014;82:1326–1334 [CrossRef]
    [Google Scholar]
  32. Romano SS, Jensen JS, Lowens MS, Morgan JL, Chambers LC et al. Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis. Clin Infect Dis 2018
    [Google Scholar]
  33. Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI et al. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008;35:119–123 [CrossRef]
    [Google Scholar]
  34. Geisler WM, Untreated Dof. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010;201:104–113 [CrossRef]
    [Google Scholar]
  35. Geisler WM, Lensing SY, Press CG, Hook EW. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis 2013;207:1850–1856 [CrossRef]
    [Google Scholar]
  36. Stupiansky NW, Van Der Pol B, Williams JA, Weaver B, Taylor SE et al. The natural history of incident gonococcal infection in adolescent women. Sex Transm Dis 2011;38:1 [CrossRef]
    [Google Scholar]
  37. van Liere GAFS, Hoebe CJPA, Dirks JAMC, Wolffs PFG, Dukers-Muijrers NHTM. Spontaneous clearance of urogenital, anorectal and oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women, MSM and heterosexual men visiting the STI clinic: a prospective cohort study. Sex Transm Infect 2019;sextrans-2018-053825 [CrossRef]
    [Google Scholar]
  38. Vandepitte J, Weiss HA, Kyakuwa N, Nakubulwa S, Muller E et al. Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda. Sex Transm Dis 2013;40:422–427 [CrossRef]
    [Google Scholar]
  39. Moi H, Haugstvedt A, Jensen JS. Spontaneous regression of untreatable Mycoplasma genitalium urethritis. Acta Derm Venereol 2015;95:732–733 [CrossRef]
    [Google Scholar]
  40. Keane FE, Thomas BJ, Gilroy CB, Renton A, Taylor-Robinson D. The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners. Int J STD AIDS 2000;11:356–360 [CrossRef]
    [Google Scholar]
  41. Kirby T. Mycoplasma genitalium: a potential new superbug. Lancet Infect Dis 2018;18:951–952 [CrossRef]
    [Google Scholar]
  42. Jensen JS, Orsum R, Dohn B, Uldum S, Worm AM et al. Mycoplasma genitalium: a cause of male urethritis?. Sex Transm Infect 1993;69:265–269 [CrossRef]
    [Google Scholar]
  43. Horner PJ, Gilroy CB, Thomas BJ, Taylor-Robinson D, Horner PJ et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. The Lancet 1993;342:582–585 [CrossRef]
    [Google Scholar]
  44. Janier M, Lassau F, Casin I, Grillot P, Scieux C et al. Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis 1995;22:244–252
    [Google Scholar]
  45. Totten PA, Schwartz MA, Sjöström KE, Kenny GE, Handsfield HH et al. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis 2001;183:269–276 [CrossRef]
    [Google Scholar]
  46. Keane FE, Thomas BJ, Gilroy CB, Renton A, Taylor-Robinson D. The association of Chlamydia trachomatis and Mycoplasma genitalium with non-gonococcal urethritis: observations on heterosexual men and their female partners. Int J STD AIDS 2000;11:435–439 [CrossRef]
    [Google Scholar]
  47. Taylor-Robinson D, Horner PJ. The role of Mycoplasma genitalium in non-gonococcal urethritis. Sex Transm Infect 2001;77:229–231 [CrossRef]
    [Google Scholar]
  48. Pépin J, Sobéla F, Deslandes S, Alary M, Wegner K et al. Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalis. Bull World Health Organ 2001;79:118–126
    [Google Scholar]
  49. Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target?. BMC Infect Dis 2015;15:343 [CrossRef]
    [Google Scholar]
  50. Bissessor M, Tabrizi SN, Bradshaw CS, Fairley CK, Hocking JS et al. The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men. Clin Microbiol Infect 2016;22:260–265 [CrossRef]
    [Google Scholar]
  51. Horner PJ, Taylor-Robinson D. Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis. Sex Transm Infect 2011;87:38–40 [CrossRef]
    [Google Scholar]
  52. Eickhoff JH, Frimodt-Møller N, Walter S, Frimodt-Møller C. A double-blind, randomized, controlled multicentre study to compare the efficacy of ciprofloxacin with pivampicillin as oral therapy for epididymitis in men over 40 years of age. BJU Int 1999;84:827–834 [CrossRef]
    [Google Scholar]
  53. Krieger JN, Riley DE, Roberts MC, Berger RE. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 1996;34:3120–3128
    [Google Scholar]
  54. Mändar R, Raukas E, Türk S, Korrovits P, Punab M. Mycoplasmas in semen of chronic prostatitis patients. Scand J Urol Nephrol 2005;39:479–482 [CrossRef]
    [Google Scholar]
  55. Ahmadi MH, Mirsalehian A, Gilani MAS, Bahador A, Talebi M. Improvement of semen parameters after antibiotic therapy in asymptomatic infertile men infected with Mycoplasma genitalium. Infection 2018;46:31–38 [CrossRef]
    [Google Scholar]
  56. Huang C, Zhu HL, Xu KR, Wang SY, Fan LQ et al. Mycoplasma and Ureaplasma infection and male infertility: a systematic review and meta-analysis. Andrology 2015;3:809–816 [CrossRef]
    [Google Scholar]
  57. Taylor-Robinson D, Gilroy CB, Horowitz S, Horowitz J. Mycoplasma genitalium in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis 1994;13:1066–1069 [CrossRef]
    [Google Scholar]
  58. Chrisment D, Machelart I, Wirth G, Lazaro E, Greib C et al. Reactive arthritis associated with Mycoplasma genitalium urethritis. Diagn Microbiol Infect Dis 2013;77:278–279 [CrossRef]
    [Google Scholar]
  59. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 2015;61:418–426 [CrossRef]
    [Google Scholar]
  60. Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. observations from a Swedish STD clinic. PLoS One 2013;8:e61481 [CrossRef]
    [Google Scholar]
  61. Simms I, Eastick K, Mallinson H, Thomas K, Gokhale R et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. J Clin Pathol 2003;56:616–618 [CrossRef]
    [Google Scholar]
  62. Clausen HF, Fedder J, Drasbek M, Nielsen PK, Toft B et al. Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod 2001;16:1866–1874 [CrossRef]
    [Google Scholar]
  63. Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC et al. Association between Mycoplasma genitalium and acute endometritis. The Lancet 2002;359:765–766 [CrossRef]
    [Google Scholar]
  64. Bradshaw CS, Latimer RL, Hocking JS, Goller JL, Read TRH et al. Clinical features and therapeutic response in women meeting criteria for presumptive treatment for pelvic inflammatory disease associated with Mycoplasma genitalium. Sex Transm Dis 2018;46:73–79
    [Google Scholar]
  65. 2018 BASHH UK national guidance for the management of infection with Mycoplasma genitalium. BASHH UK Natl Guidel 2018;http://www.sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium#management
    [Google Scholar]
  66. Australian Sexual Health Alliance 2018; Mycoplasma genitalium - Australian STI management guidelines for primay care. http://www.sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium#management
  67. Slifirski JB, Vodstrcil LA, Fairley CK, Ong JJ, Chow EPF et al. Mycoplasma genitalium infection in adults reporting sexual contact with infected partners, Australia, 2008-2016. Emerg Infect Dis 2017;23:1826–1833 [CrossRef]
    [Google Scholar]
  68. Bradshaw CS, Horner PJ, Jensen JS, White PJ. Syndromic management of STIs and the threat of untreatable Mycoplasma genitalium. Lancet Infect Dis 2018;18:251–252 [CrossRef]
    [Google Scholar]
  69. Horner PJ, Martin DH. Mycoplasma genitalium infection in men. J Infect Dis 2017;216:S396–S405 [CrossRef]
    [Google Scholar]
  70. Hamasuna R, Osada Y, Jensen JS. Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR. Antimicrob Agents Chemother 2005;49:4993–4998 [CrossRef]
    [Google Scholar]
  71. Hamasuna R, Jensen JS, Osada Y. Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrob Agents Chemother 2009;53:4938–4939 [CrossRef]
    [Google Scholar]
  72. Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M et al. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clin Microbiol Infect 2018;24:533–539 [CrossRef]
    [Google Scholar]
  73. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium –positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008;47:1546–1553 [CrossRef]
    [Google Scholar]
  74. Asenjo A, Kusters JG, Severs TT, Alós J-I. Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides. Enfermedades Infecciosas y Microbiología Clínica 2018;36:169–171 [CrossRef]
    [Google Scholar]
  75. Pitt R, Fifer H, Woodford N, Alexander S. Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services in England. Sex Transm Infect 2018;94:9–13 [CrossRef]
    [Google Scholar]
  76. Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis 2015;61:1389–1399 [CrossRef]
    [Google Scholar]
  77. Horner P, Ingle SM, Garrett F, Blee K, Kong F et al. Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis. Sex Transm Infect 2018;94:14–20 [CrossRef]
    [Google Scholar]
  78. Read TRH, Fairley CK, Tabrizi SN, Bissessor M, Vodstrcil L et al. Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium : Impact on Treatment Outcome and Resistance. CLINID 2017;64:250–256 [CrossRef]
    [Google Scholar]
  79. Read TRH, Fairley CK, Murray GL, Jensen JS, Danielewski J et al. Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium Infections: a prospective evaluation. Clin Infect Dis 2019;68:554–560 [CrossRef]
    [Google Scholar]
  80. Li Y, Le W-J, Li S, Cao Y-P, Su X-H. Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. Int J STD AIDS 2017;28:1106–1114 [CrossRef]
    [Google Scholar]
  81. Couldwell DL, Tagg KA, Jeoffreys NJ, Gilbert GL. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS 2013;24:822–828 [CrossRef]
    [Google Scholar]
  82. Richter SS, Patel JB. Mechanisms of Resistance to Antibacterial Agents* In: Manual of Clinical Microbiology, 11th Edition. American Society of Microbiology; 2015; pp1212–1245
    [Google Scholar]
  83. Deguchi T, Ito S, Yasuda M, Sato Y, Uchida C et al. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan. J Infect Chemother 2018;24:861–867 [CrossRef]
    [Google Scholar]
  84. Hamasuna R, Le PT, Kutsuna S, Furubayashi K, Matsumoto M et al. Mutations in parC and gyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. PLoS One 2018;13:e0198355 [CrossRef]
    [Google Scholar]
  85. Kikuchi M, Ito S, Yasuda M, Tsuchiya T, Hatazaki K et al. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. J Antimicrob Chemother 2014;69:2376–2382 [CrossRef]
    [Google Scholar]
  86. Ito S, Shimada Y, Yamaguchi Y, Yasuda M, Yokoi S et al. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 G dose of azithromycin. Sex Transm Infect 2011;87:412–414 [CrossRef]
    [Google Scholar]
  87. Takahashi S, Hamasuna R, Yasuda M, Ito S, Ito K et al. Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother 2013;19:941–945 [CrossRef]
    [Google Scholar]
  88. Deguchi T, Ito S, Yasuda M, Kondo H, Yamada Y et al. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in gyrA and parC in Japan. J Infect Chemother 2017;23:648–650 [CrossRef]
    [Google Scholar]
  89. Pond MJ, Nori AV, Witney AA, Lopeman RC, Butcher PD et al. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 2014;58:631–637 [CrossRef]
    [Google Scholar]
  90. Braam JF, van Dommelen L, Henquet CJM, van de Bovenkamp JHB, Kusters JG. Multidrug-Resistant Mycoplasma genitalium infections in Europe. Eur J Clin Microbiol Infect Dis 2017;36:1565–1567 [CrossRef]
    [Google Scholar]
  91. Soni S, Parkhouse A, Dean G. Macrolide and quinolone-resistant Mycoplasma genitalium in a man with persistent urethritis: the tip of the British iceberg?. Sex Transm Infect 2017;93:556–557 [CrossRef]
    [Google Scholar]
  92. Peyriere H, Makinson A, Marchandin H, Reynes J. Doxycycline in the management of sexually transmitted infections. Journal of Antimicrobial Chemotherapy 2018;73:p. 553–.563
    [Google Scholar]
  93. Golden MR, Kenny GK, Jensen NL, Totten PA, Khosopour CM et al. O19.1 azithromycin and doxycycline resistance profiles of Mycoplasma genitalium and association with treatment outcomes. Sex Transm Infect 2013;89:A62.3–A62
    [Google Scholar]
  94. Blanchard A, Bébéar C. The evolution of Mycoplasma genitalium. Ann N Y Acad Sci 2011;1230:E61–E64 [CrossRef]
    [Google Scholar]
  95. Mena LA, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009;48:1649–1654 [CrossRef]
    [Google Scholar]
  96. Schwebke JR, Rompalo A, Taylor S, Seña AC, Martin DH et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis 2011;52:163–170 [CrossRef]
    [Google Scholar]
  97. Manhart LE, Gillespie CW, Lowens MS, Khosropour CM, Colombara DV et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clinical Infectious Diseases 2013;56:Oxford University Press934–942 [CrossRef]
    [Google Scholar]
  98. Glaser AM, Geisler WM, Ratliff AE, Xiao L, Waites KB et al. Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline. International Journal of STD and AIDS [Internet] 2019
    [Google Scholar]
  99. McGowin CL, Totten PA. The unique microbiology and molecular pathogenesis of Mycoplasma genitalium. J Infect Dis 2017;216:S382–S388 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000830
Loading
/content/journal/micro/10.1099/mic.0.000830
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error